Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Alpern Insider Profile
4 Followers
Robert Alpern, Director at AbbVie, holds 143.06K shares in Tricida (Ticker: TCDA), holds 28.44K shares in AbbVie (Ticker: ABBV), holds 32.38K shares in Abbott Labs (Ticker: ABT).
Robert Alpern has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Alpern holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robert Alpern
Robert Alpern's Trading History
AbbVie
May 12, 2020
Director
Uninformative Buy
―
$2.98M
Tricida
Jun 15, 2020
Director
Uninformative Buy
―
$1.07M
Abbott Labs
Apr 28, 2020
Director
Uninformative Buy
―
$3.48M
List of latest transactions for each holding click on a transaction to see Robert Alpern's performance on stock
You May Also Like
Robert Alpern insider profile FAQ
What is the percentage of profitable transactions made by Robert Alpern?
The percentage of profitable transactions made by Robert Alpern is ―.
What is the average return per transaction made by Robert Alpern?
The average return per transaction made by Robert Alpern is ―.
What stocks does Robert Alpern hold?
Robert Alpern holds: ABBV, TCDA, ABT stocks.
What was Robert Alpern’s latest transaction?
Robert Alpern latest transaction was an Uninformative Buy of ―.
What was Robert Alpern's most profitable transaction?
Robert Alpern’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert Alpern's role in AbbVie?
Robert Alpern's role in AbbVie is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.